temozolomide (dose-dense)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for temozolomide (dose-dense), covering 2020-09-14 to 2023-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III [Phase 3]